Our Products and Expertise
Commercial Pharmaceuticals
STERILE FOCUS BRANDS
REGIONAL BRANDS
Anaesthetics

Aspen has a comprehensive portfolio of 20 mature Anaesthetics Brands, having acquired two complementary Anaesthetics portfolios from AstraZeneca and GSK. Our diverse product range includes general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents, making Aspen a leading global supplier in the Anaesthetics category (House of Anesthesia), outside of the USA.
Thrombosis

Our Thrombosis portfolio is a global offering (excluding USA) which is comprised largely of a broad range of specialist injectable anticoagulants. In addition to the heparin based anticoagulant portfolio, Aspen also produces Arixtra, a Xa inhibitor with a wide range of indications, including VTE treatment and prophylaxis, deep vein thrombosis, pulmonary embolism and acute coronary syndrome treatment.
High Potency & Cytotoxics, Women's Health and Pain Management

Our Regional Brands are geographically diverse and include products for high Potency & Cytotoxics, Women's Health and Pain Management. The products within this segment have strong brand equity and are actively promoted through our experienced regional marketing and sales teams.
Looking for more information?
Get in touch to learn more about our products and services
Key Products
- Diprivan
- Emla
- Marcaine
- Naropin
- Ultiva
- Xylocaine
Key Products
- Arixtra
- Fraxiparine
- Orgaran
Key Products
- Eltroxin
- Gracial
- Imuran
- Ovestin
- Solpadeine
- Zyloric
Commercial Pharmaceuticals
STERILE FOCUS BRANDS
Anaesthetics

Aspen has a comprehensive portfolio of 20 mature Anaesthetics Brands, having acquired two complementary Anaesthetics portfolios from AstraZeneca and GSK. Our diverse product range includes general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents, making Aspen a leading global supplier in the Anaesthetics category, outside of the USA.
Key Products
- Diprivan
- Emla
- Marcaine
- Naropin
- Ultiva
- Xylocaine
Thrombosis

Our Thrombosis portfolio is a global offering (excluding USA) which is comprised largely of a broad range of specialist injectable anticoagulants. In addition to the heparin based anticoagulant portfolio, Aspen also produces Arixtra, a Xa inhibitor with a wide range of indications, including CTE treatment and prophylaxis, deep vein thrombosis, pulmonary embolism and acute coronary syndrome treatment.
Key Products
- Arixtra
- Fraxiparine
- Orgaran
REGIONAL BRANDS
High Potency & Cytotoxics, Women's Health and Pain Management

Our Regional Brands are geographically diverse and include products for high Potency & Cytotoxics, Women's Health and Pain Management. The products within this segment have strong brand equity and are actively promoted through our experienced regional marketing and sales teams.
Key Products
- Eltroxin
- Gracial
- Imuran
- Ovestin
- Solpadeine
- Zyloric
Looking for more information?
Get in touch to learn more about our products and services